GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type. (Q47990608)

http://europepmc.org/abstract/MED/28903472

7 February 2018

title

GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type. (English)

1 reference

http://europepmc.org/abstract/MED/28903472

7 February 2018

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28903472%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

Madelon van Wely

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28903472%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

7

F van der Veen

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28903472%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

author name string

C B Lambalk

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28903472%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

F R Banga

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28903472%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

J A Huirne

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28903472%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

M Toftager

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28903472%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

R Homburg

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28903472%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

publication date

1 September 2017

1 reference

http://europepmc.org/abstract/MED/28903472

7 February 2018

published in

Human Reproduction Update

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28903472%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28903472%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

page(s)

560-579

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28903472%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28903472%20AND%20SRC:MED&resulttype=core&format=json

Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. European Cetrorelix Study Group

13 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Optimizing GnRH antagonist administration: meta-analysis of fixed versus flexible protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Gonadotrophin-releasing hormone antagonists for assisted conception: a Cochrane review

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Milder ovarian stimulation for in-vitro fertilization reduces aneuploidy in the human preimplantation embryo: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Ongoing pregnancy qualifies best as the primary outcome measure of choice in trials in reproductive medicine: an opinion paper

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Comparison of assisted reproductive technology outcomes in infertile women with polycystic ovary syndrome: In vitro maturation, GnRH agonist, and GnRH antagonist cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

GnRH agonist versus GnRH antagonist in assisted reproduction cycles: oocyte morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

A comparative study of luteal estradiol pre-treatment in GnRH antagonist protocols and in micro dose flare protocols for poor-responding patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Follicular growth and oocyte maturation in GnRH agonist and antagonist protocols for in vitro fertilisation and embryo transfer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Induction of multiple follicular development by a single dose of long-acting recombinant follicle-Stimulating hormone (FSH-CTP, corifollitropin alfa) for controlled ovarian stimulation before in vitro fertilization.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

A randomized trial of microdose leuprolide acetate protocol versus luteal phase ganirelix protocol in predicted poor responders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Follicular fluid vascular endothelial growth factor concentrations are increased during GnRH antagonist/FSH ovarian stimulation cycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Comparing GnRH agonist long protocol and GnRH antagonist protocol in outcome the first cycle of ART.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Luteal phase characteristics following GnRH antagonist or agonist treatment - a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Cycle scheduling with oral contraceptive pills in the GnRH antagonist protocol vs the long protocol: a randomized, controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

IVF/ICSI outcomes of the OCP plus GnRH agonist protocol versus the OCP plus GnRH antagonist fixed protocol in women with PCOS: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

A mild treatment strategy for in-vitro fertilisation: a randomised non-inferiority trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

GnRH-antagonist programming versus GnRH agonist protocol: a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Comparison of gonadotropin-releasing hormone agonists and antagonists in assisted reproduction cycles of polycystic ovarian syndrome patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Comparisons of different dosages of gonadotropin-releasing hormone (GnRH) antagonist, short-acting form and single, half-dose, long-acting form of GnRH agonist during controlled ovarian hyperstimulation and in vitro fertilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Dose-finding study of daily gonadotropin-releasing hormone (GnRH) antagonist for the prevention of premature luteinizing hormone surges in IVF/ICSI patients: antide and hormone levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Contemporary pharmacological manipulation in assisted reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Cetrorelix in an oral contraceptive-pretreated stimulation cycle compared with buserelin in IVF/ICSI patients treated with r-hFSH: a randomized, multicentre, phase IIIb study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Are GnRH antagonists comparable to agonists for use in IVF?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Dose-finding study of triptorelin acetate for prevention of a premature LH surge in IVF: a prospective, randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Comparison of mild stimulation and conventional stimulation in ART outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

GnRH antagonist multiple dose protocol with oral contraceptive pill pretreatment in poor responders undergoing IVF/ICSI

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Effectiveness of GnRH antagonist multiple dose protocol applied during early and late follicular phase compared with GnRH agonist long protocol in non-obese and obese patients with polycystic ovary syndrome undergoing IVF/ICSI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Efficacy of low-dose human chorionic gonadotropin (hCG) in a GnRH antagonist protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Fixed versus flexible gonadotropin-releasing hormone antagonist administration in in vitro fertilization: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Comparison of embryological and clinical outcome in GnRH antagonist vs. GnRH agonist protocols for in vitro fertilization in PCOS non-obese patients. A prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Ovarian response and follicular development for single-dose and multiple-dose protocols for gonadotropin-releasing hormone antagonist administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Comparison of outcome of clomiphene citrate/human menopausal gonadotropin/cetrorelix protocol and buserelin long protocol--a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

A modified gonadotropin-releasing hormone (GnRH) antagonist protocol failed to increase clinical pregnancy rates in comparison with the long GnRH protocol

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

GnRH antagonist in IVF poor-responder patients: results of a randomized trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Prospective, randomized, comparative study of leuprorelin + human menopausal gonadotropins versus ganirelix + recombinant follicle-stimulating hormone in oocyte donors and pregnancy rates among the corresponding recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Randomized, comparative pilot study of pituitary suppression with depot leuprorelin versus cetrorelix acetate 3 mg in gonadotropin stimulation protocols for oocyte donors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Comparison of GnRH agonists and antagonists in normoresponder IVF/ICSI in Turkish female patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Serum anti-Müllerian hormone and FSH: prediction of live birth and extremes of response in stimulated cycles--implications for individualization of therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

GnRH agonist versus GnRH antagonist in oocyte donation cycles: a prospective randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

A randomized controlled trial of the GnRH antagonist ganirelix in Chinese normal responders: high efficacy and pregnancy rates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

GnRH antagonist versus long GnRH agonist protocol in poor IVF responders: a randomized clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

"Mild" vs. "long" protocol for controlled ovarian hyperstimulation in patients with expected poor ovarian responsiveness undergoing in vitro fertilization (IVF): a large prospective randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Comparative efficacy and safety of cetrorelix with or without mid-cycle recombinant LH and leuprolide acetate for inhibition of premature LH surges in assisted reproduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Cetrorelix protocol versus gonadotropin-releasing hormone analog suppression long protocol for superovulation in intracytoplasmic sperm injection patients older than 40.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Ovarian stimulation with daily late follicular phase administration of low-dose human chorionic gonadotropin for in vitro fertilization: a prospective, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Long gonadotropin-releasing hormone agonist versus short agonist versus antagonist regimens in poor responders undergoing in vitro fertilization: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

GnRH antagonists in ovarian stimulation for IVF.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Comparison of multiple dose GnRH antagonist and minidose long agonist protocols in poor responders undergoing in vitro fertilization: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Comparison of GnRH antagonist with long GnRH agonist protocol after OCP pretreatment in PCOs patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Comparable effectiveness using flexible single-dose GnRH antagonist (cetrorelix) and single-dose long GnRH agonist (goserelin) protocol for IVF cycles--a prospective, randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Follicular oestradiol and VEGF after GnRH antagonists or GnRH agonists in women with PCOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

A randomised study of GnRH antagonist (cetrorelix) versus agonist (busereline) for controlled ovarian stimulation: effect on safety and efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

IVF/ICSI outcomes between cycles with luteal estradiol (E2) pre-treatment before GnRH antagonist protocol and standard long GnRH agonist protocol: a prospective and randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

Comparisons of GnRH antagonist versus GnRH agonist protocol in supposed normal ovarian responders undergoing IVF: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FHUMUPD%2FDMX017

The association of HMGB1 gene with the prognosis of HCC.

21 January 2018

1 reference

COCI

https://opencitations.net/index/api/v1/citations/10.1371/JOURNAL.PONE.0089097

9 February 2024

Identifiers

DOI

10.1093/HUMUPD/DMX017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28903472%20AND%20SRC:MED&resulttype=core&format=json

13 June 2020

1 reference